Artificial Intelligence (Pattern Recognition) in Musculoskeletal Imaging: The Future or Hype?
Clinical Snapshot
PICO Framework
| P — Population | Patients undergoing musculoskeletal imaging across clinical settings and scanner platforms |
| I — Intervention | Artificial intelligence and automated pattern recognition tools applied to musculoskeletal radiology tasks (fracture detection, segmentation, automated reporting) |
| C — Comparator | Conventional radiologist-led interpretation and reporting workflows |
| O — Outcomes | Diagnostic accuracy, workflow efficiency, generalisability across institutions and vendors, regulatory compliance, clinical deployment feasibility, and ethical implications of automation |
Bottom Line
This narrative review from a multinational team of musculoskeletal radiologists provides a balanced and timely appraisal of AI and automated pattern recognition in musculoskeletal imaging. The authors correctly identify that the field is transitioning from an initial hype phase into a period requiring rigorous clinical validation. Key strengths include the breadth of outcomes addressed — spanning diagnostic performance, workflow integration, regulatory compliance, and the ethical implications of opaque deep learning models. The central argument, that AI must move beyond narrow single-task performance toward generalisable, multi-institutionally validated tools to function as a genuine clinical copilot, is well-reasoned and evidence-consistent. However, as a narrative review without a systematic search strategy or formal quality appraisal, the synthesis is vulnerable to selective citation bias, compounded by at least one author's commercial affiliation with an AI radiology company. Clinicians and health system decision-makers should treat the conclusions as expert opinion rather than Level 1 evidence. For Australian practice, TGA SaMD registration requirements and the absence of MBS reimbursement pathways for AI-assisted reporting remain practical barriers that this review does not specifically address. The paper is best used as an orientation document for clinicians and administrators evaluating AI radiology procurement, not as a definitive evidence base for clinical policy.
Key Findings
P Value: Not reported
Effect Size: Not reported — narrative review without quantitative meta-analysis
Primary Outcome: Qualitative synthesis of the current state of AI and automated pattern recognition in musculoskeletal radiology, encompassing fracture detection, automated segmentation, and automated reporting
Nnt Or Sensitivity: Not reported — no pooled diagnostic accuracy metrics (sensitivity, specificity, AUC) are presented in the abstract; individual study performance data may be discussed in the full text but are not summarised here
Confidence Interval: Not reported
Clinical Application
The review's conclusions — that AI holds genuine transformative potential but requires robust multi-institutional validation before widespread deployment — are directly actionable for clinical governance and procurement decisions. The emphasis on workflow integration and regulatory compliance is practically relevant for institutions considering AI radiology tools. In Australia, AI-based medical imaging tools require TGA registration as Software as a Medical Device (SaMD) under the Therapeutic Goods (Medical Devices) Regulations 2002, with classification dependent on intended use and risk level. The TGA's Digital Health and AI regulatory framework is actively evolving, and the barriers to deployment described in this review — vendor generalisability, workflow integration, regulatory hurdles — are directly applicable to the Australian context. The Royal Australian and New Zealand College of Radiologists (RANZCR) has published AI standards and a position statement on AI in radiology (2019, updated guidance ongoing) that align with the review's call for multi-institutional validation. Medicare Benefits Schedule (MBS) reimbursement for AI-assisted reporting remains unresolved in Australia, representing a significant adoption barrier not explicitly addressed by this review. The RACGP's increasing emphasis on appropriate imaging referral also intersects with AI-driven efficiency claims. Radiologists, orthopaedic surgeons, rheumatologists, sports medicine physicians, and emergency clinicians who order or interpret musculoskeletal imaging studies; hospital administrators and health informaticians evaluating AI tool procurement
Abstract
Artificial intelligence and automated pattern recognition, in particular, have been described as the next frontier in musculoskeletal imaging. However, as the initial hype phase transitions into clinical reality, an essential evaluation of these technologies is required. This narrative review examines the dichotomy between a potential future in which artificial intelligence offers unprecedented efficiency in automatizing multiple tasks in musculoskeletal radiology, from fracture detection, automated segmentation, to automated reporting, versus the hype, characterized by deep learning models that lack generalizability across different scanner vendors and patient populations. We explore the black box nature of deep learning and the ethical implications of automation. By analyzing current barriers to deployment, including workflow integration and regulatory hurdles, this article argues that although artificial intelligence holds transformative potential for musculoskeletal radiology, its success depends on moving beyond narrow diagnostic tasks toward robust multi-institutional validation, to evolve from a speculative trend into an essential clinical copilot tool.
References
- 1.Tordjman, M., Regnard, N.-E., Mihoubi, F., Rizk, B., & Guermazi, A. (2026). Artificial intelligence (pattern recognition) in musculoskeletal imaging: The future or hype? Seminars in Musculoskeletal Radiology. https://doi.org/10.1055/a-2818-3827
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service